Publications by authors named "Len Farol"

Claim this Profile
T
Total Marrow and Lymphoid Irradiation with Post-Transplantation Cyclophosphamide for Patients with AML in Remission.
Anthony S Stein, Monzr M Al Malki, Dongyun Yang, Joycelynne M Palmer, Ni-Chun Tsai, Len Farol

Transplant Cell Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial.
Ibrahim Aldoss, Corinna La Rosa, Lindsey R Baden, Jeffrey Longmate, Ella J Ariza-Heredia, Len Farol

Ann Intern Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia.
Anthony Stein, Joycelynne Palmer, Ni-Chun Tsai, Monzr M Al Malki, Ibrahim Aldoss, Len Farol

Biol Blood Marrow Transplant· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial.
Ryotaro Nakamura, Corinna La Rosa, Jeffrey Longmate, Jennifer Drake, Cynthia Slape, Len Farol

Lancet Haematol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin is associated with improved progression-free survival after allogeneic transplantation for Hodgkin lymphoma.
Robert Chen, Joycelynne M Palmer, Ni-Chun Tsai, Sandra H Thomas, Tanya Siddiqi, Len Farol

Biol Blood Marrow Transplant· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of intravenous plerixafor following cyclophosphamide mobilization in patients with multiple myeloma.
Amrita Y Krishnan, Shirong Wang, Joycelynne M Palmer, Ni-Chun Tsai, Sandra H Thomas, Len Farol

Leuk Lymphoma· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphoma.
Robert Chen, Joycelynne M Palmer, Sandra H Thomas, Ni-Chun Tsai, Len Farol

Blood· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myeloma.
Firoozeh Sahebi, Paul H Frankel, Len Farol, Amrita Y Krishnan, Ji-lian Cai

Biol Blood Marrow Transplant· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bexarotene: a clinical review.
Len T Farol, Kenneth B Hymes

Expert Rev Anticancer Ther· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis